Edoardo G. Giannini

16.1k citations

263 papers · 8.6k indexed · 2 hit papers · h-index 48

Impact in

Hepatology top 0.1%
- Liver Disease and Transplantation
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
Epidemiology top 0.2%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies

Papers in

Hepatology 154
- Liver Disease and Transplantation 78
- Hepatocellular Carcinoma Treatment and Prognosis 65
- Hepatitis C virus research 60
Gastroenterology 33
- Gastroesophageal reflux and treatments 24

Co-authors: Vincenzo Savarino Roberto Testa Federica Botta Domenico Risso Franco Trevisani Fabio Farinati Alberto Fasoli Emanuela Testa
Journals: Digestive and Liver Disease (27 papers)The American Journal of Gastroenterology (17 papers)Journal of Hepatology (17 papers)Liver International (14 papers)Digestive Diseases and Sciences (12 papers)
Partner nations: Italy United States United Kingdom

In The Last Decade

Edoardo G. Giannini

252 papers receiving 8.4k citations

Hit Papers

align trajectories log scale

EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis 2022 · 165 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Journal of Hepatology
2005 Canadian Medical Association Journal

Peers

Countries citing papers authored by Edoardo G. Giannini

Since Specialization

Citations

This map shows the geographic impact of Edoardo G. Giannini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edoardo G. Giannini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edoardo G. Giannini more than expected).

Fields of papers citing papers by Edoardo G. Giannini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edoardo G. Giannini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edoardo G. Giannini. The network helps show where Edoardo G. Giannini may publish in the future.

Co-authors

The 25 scholars most cited alongside Edoardo G. Giannini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edoardo G. Giannini Line = papers co-authored together Edoardo G. Giannini links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The Therapeutic Pipeline for Eosinophilic Esophagitis: Current Landscape and Future Directions Pharmaceuticals ·Andrea Pasta, Luisa Bertin, Amir Mari, Francesco Calabrese, Amir Farah, Giulia Navazzotti, Matteo Ghisa, Vincenzo Savarino, Edoardo Savarino, Edoardo G. Giannini, Elisa Marabotto	2025	0
2	Food Intolerances, Food Allergies and IBS: Lights and Shadows Nutrients ·Andrea Pasta, Elena Formisano, Francesco Calabrese, Maria Plaz Torres, Giorgia Bodini, Elisa Marabotto, Livia Pisciotta, Edoardo G. Giannini, Manuele Furnari	2024	15
3	Diagnostic delay in achalasia Digestive and Liver Disease ·Andrea Pasta, Francesco Calabrese, Andrea Ghezzi, Edoardo Savarino, Vincenzo Savarino, Patrizia Zentilin, Manuele Furnari, Giorgia Bodini, Edoardo G. Giannini, Elisa Marabotto	2024	4
4	Comparison of the Safety and Efficacy of Ustekinumab and Vedolizumab in Patients with Crohn’s Disease: A Systematic Review and Meta-Analysis of Propensity Score Matched Cohort Studies SHILAP Revista de lepidopterología ·Andrea Pasta, Francesco Calabrese, Elisa Marabotto, Manuele Furnari, Maria Giulia Demarzo, Raffaele Pellegrino, Antonietta Gerarda Gravina, Alessandro Federico, Edoardo G. Giannini, Giorgia Bodini	2024	1
5	Second‐Line Treatment for Patients With Primary Biliary Cholangitis: A Systematic Review With Network Meta‐Analysis Liver International ·Edoardo G. Giannini, Andrea Pasta, Francesco Calabrese, Sara Labanca, Simona Marenco, Giulia Pieri, Maria Corina Plaz Torres, Mario Strazzabosco	2024	7
6	Are Small Molecules Effective in Treating Inflammatory Pouch Disorders Following Ileal Pouch-Anal Anastomosis for Ulcerative Colitis? Here Is Where We Stand Biomolecules ·Antonietta Gerarda Gravina, Raffaele Pellegrino, Giovanna Palladino, Giuseppe Imperio, Francesco Calabrese, Andrea Pasta, Edoardo G. Giannini, Alessandro Federico, Giorgia Bodini	2024	4
7	Can High-Frequency Intraoral Ultrasound Predict Histological Risk Factors in Oral Squamous Cell Carcinoma? A Preliminary Experience Cancers ·Simone Caprioli, Giorgio‐Gregory Giordano, Alessia Pennacchi, Valentina Campagnari, Andrea Iandelli, Giampiero Parrinello, Cristina Conforti, Riccardo Gili, Edoardo G. Giannini, Elisa Marabotto, Stefano Kayali, Bernardo Bianchi, Giorgio Peretti, Giuseppe Cittadini, Filippo Marchi	2023	1
8	Response to COVID-19 Vaccination in Patients with Inflammatory Bowel Disease on Biological Treatment SHILAP Revista de lepidopterología ·Giorgia Bodini, Elisabetta Giuliana, Irene Giberti, Giulia Guarona, Federica Benvenuto, Elisa Ferretti, Maria Giulia Demarzo, Giorgio Da Rin, Giancarlo Icardi, Edoardo G. Giannini	2022	1
9	Colorectal Cancer in Inflammatory Bowel Diseases: Epidemiology and Prevention: A Review Cancers ·Elisa Marabotto, Stefano Kayali, Silvia Buccilli, Francesca Levo, Giorgia Bodini, Edoardo G. Giannini, Vincenzo Savarino, Edoardo Savarino	2022	33
10	Procedure‐related bleeding risk in patients with cirrhosis and severe thrombocytopenia European Journal of Clinical Investigation ·Domenico Alvaro, N. Caporaso, Edoardo G. Giannini, A. Iacobellis, Maria Cristina Morelli, Pierluigi Toniutto, Francesco Violi, (unknown)	2021	27
11	Dietary Management of Eosinophilic Esophagitis: Tailoring the Approach Nutrients ·Pierfrancesco Visaggi, Lucia Mariani, Veronica Pardi, Emma Maria Rosi, Camilla Pugno, Massimo Bellini, Fabiana Zingone, Matteo Ghisa, Elisa Marabotto, Edoardo G. Giannini, Vincenzo Savarino, Santino Marchi, Edoardo Savarino, Nicola de Bortoli	2021	18
12	Overview of Prognostic Systems for Hepatocellular Carcinoma and ITA.LI.CA External Validation of MESH and CNLC Classifications Cancers ·Alessandro Vitale, Fabio Farinati, Michele Finotti, Chiara Di Renzo, Giuseppina Brancaccio, Fabio Piscaglia, Giuseppe Cabibbo, Eugenio Caturelli, Gabriele Missale, Fabio Marra, Rodolfo Sacco, Edoardo G. Giannini, Franco Trevisani, Umberto Cillo, (unknown), (unknown)	2021	29
13	Prevention Strategies for Esophageal Cancer—An Expert Review Cancers ·Elisa Marabotto, Gaia Pellegatta, Afscin Djahandideh Sheijani, Sebastiano Ziola, Patrizia Zentilin, Maria Giulia De Marzo, Edoardo G. Giannini, Matteo Ghisa, Brigida Barberio, Marco Scarpa, Imerio Angriman, Matteo Fassan, Vincenzo Savarino, Edoardo Savarino	2021	26
14	Obeticholic Acid Improves Aminotransferases Early during Treatment in Patients with Primary Biliary Cholangitis Not Responding to Ursodeoxycholic Acid: A Study in Clinical Practice SHILAP Revista de lepidopterología ·Sara Labanca, Valentina Cacciato, Paolo Borro, Simona Marenco, Giulia Pieri, A. Picciotto, Maria Corina Plaz Torres, Edoardo G. Giannini	2021	2
15	Long term results of down-staging and liver transplantation for patients with hepatocellular carcinoma beyond the conventional criteria Scientific Reports ·Matteo Ravaioli, Federica Odaldi, Alessandro Cucchetti, Franco Trevisani, Fabio Piscaglia, Vanessa De Pace, Valentina Rosa Bertuzzo, Flavia Neri, Rita Golfieri, Alberta Cappelli, Antonietta D’Errico, Matteo Cescon, Massimo Del Gaudio, Guido Fallani, Antonio Daniele Pinna, Maria Cristina Morelli, Francesca Ciccarese, Maria Di Marco, Fabio Farinati, Edoardo G. Giannini	2019	17
16	Overview of Immune Checkpoint Inhibitors Therapy for Hepatocellular Carcinoma, and The ITA.LI.CA Cohort Derived Estimate of Amenability Rate to Immune Checkpoint Inhibitors in Clinical Practice Cancers ·Edoardo G. Giannini, Andrea Aglitti, Mauro Borzio, Martina Gambato, Maria Guarino, Massimo Iavarone, Quirino Lai, Giovanni Battista Levi Sandri, Fabio Melandro, Filomena Morisco, Francesca Romana Ponziani, Maria Rendina, Francesco Paolo Russo, Rodolfo Sacco, Mauro Viganò, Alessandro Vitale, Franco Trevisani, (unknown)	2019	45
17	Treatment of early stage chronic hepatitis C virus infection Expert Review of Clinical Pharmacology ·Francesca Romana Ponziani, Luca Miele, Annalisa Tortora, Manuele Furnari, Giorgia Bodini, Maurizio Pompili, Antonio Gasbarrini, Edoardo G. Giannini	2018	4
18	Non‐cirrhotic thrombocytopenic patients with hepatitis C virus: Characteristics and outcome of antiviral therapy Journal of Gastroenterology and Hepatology ·Edoardo G. Giannini, Nezam H. Afdhal, Samuel H. Sigal, Andrew J. Muir, K. Rajender Reddy, Shanthi Vijayaraghavan, Magdy Elkashab, Manuel Romero‐Gómez, Geoffrey Dusheiko, Malini Iyengar, Sandra Y. Vasey, Fiona Campbell, Dickens Theodore	2015	4
19	Hepatocellular Carcinoma Is the Most Frequent Final Diagnosis of Focal Liver Lesions Identified in a Cross-Sectional Evaluation of Patients with Chronic Liver Disease in Saudi Arabia SHILAP Revista de lepidopterología ·Adnan Agha, Manuele Furnari, Rafaat Chakik, Mamdouh M. Ali, Dib Alsaudi, Mohammed Bazeed, Vincenzo Savarino, Edoardo G. Giannini	2015	2
20	FINAL RESULTS OF ENABLE 1, A PHASE 3, MULTICENTER STUDY OF ELTROMBOPAG AS AN ADJUNCT FOR ANTIVIRAL TREATMENT OF HEPATITIS C VIRUS-RELATED CHRONIC LIVER DISEASE ASSOCIATED WITH THROMBOCYTOPENIA UCL Discovery (University College London) ·Nezam H. Afdhal, Geoffrey Dusheiko, Edoardo G. Giannini, Pei‐Jer Chen, Kwang‐Hyub Han, A Moshin, M. Rodríguez‐Torres, Sorin Rugină, Eric Lawitz, ML Shiffman, G.N. Tayyab, F. Poordad, Y. Mostafa Kamel, Andrés Brainsky, James Geib, S.Y. Vasey, Rita Patwardhan, FM Campbell, Dickens Theodore	2011	12

About Edoardo G. Giannini

Edoardo G. Giannini is a scholar working on Hepatology, Gastroenterology, Epidemiology, Surgery and Pharmacology, having authored 263 papers that have together received 8.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (152 papers), Liver Disease and Transplantation (78 papers), Hepatocellular Carcinoma Treatment and Prognosis (65 papers), Hepatitis C virus research (60 papers), Gastroesophageal reflux and treatments (24 papers), Hepatitis B Virus Studies (23 papers), Eosinophilic Esophagitis (23 papers) and Helicobacter pylori-related gastroenterology studies (21 papers). The work is most often cited by research in Hepatology (4.9k citations), Epidemiology (5.0k citations), Gastroenterology (598 citations), Pharmacology (438 citations) and Surgery (2.0k citations). Edoardo G. Giannini has collaborated with scholars based in Italy, United States and United Kingdom. Frequent co-authors include Vincenzo Savarino, Roberto Testa, Federica Botta, Domenico Risso, Franco Trevisani, Fabio Farinati, Alberto Fasoli, Emanuela Testa, Eugenio Caturelli and Marco Zoli. Their work appears in journals such as Digestive and Liver Disease, The American Journal of Gastroenterology, Journal of Hepatology, Liver International and Digestive Diseases and Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact